LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article: Antioxidants in the Prevention of Cisplatin-Induced Hearing Loss: A Systematic Review and Meta-Analysis

    King, Rich Ericson C. / Ong, Kimberly Mae C.

    Asian Journal of Oncology

    2022  

    Abstract: Background: Cisplatin is a commonly used chemotherapeutic drug that is associated with irreversible hearing loss. A number of antioxidants have been investigated for prevention, but data have so far been inconclusive.: Objective: The objective of ... ...

    Abstract Background: Cisplatin is a commonly used chemotherapeutic drug that is associated with irreversible hearing loss. A number of antioxidants have been investigated for prevention, but data have so far been inconclusive.
    Objective: The objective of this study was to assess the efficacy of various antioxidant therapies in preventing hearing loss among adult patients treated with cisplatin.
    Methodology: We searched for controlled clinical trials evaluating various antioxidants as prevention against cisplatin-induced hearing loss in adults. The primary outcome is the proportion of patients with hearing loss. Secondary outcomes include audiometric threshold shifts, tinnitus, tumor response, adverse events, and quality of life.
    Results: Thirteen randomized trials comprising of nine antioxidant therapies were included. Only coenzyme Q with multivitamins demonstrated significant benefit in preventing cisplatin-induced hearing loss (relative risk: 0.15, 95% confidence interval: 0.04–0.58) in a small study, while data for the rest of the agents were inconclusive. Audiometric threshold shifts were significantly lower in the intervention arm for aspirin, vitamin E, and transtympanic dexamethasone. The available data on tumor response was inconclusive, with no definite evidence of diminished tumor response noted. Adverse events noted include mild ear pain particularly for transtympanic therapies. There was no data available on quality of life.
    Conclusion: The current available evidence is so far insufficient to establish any benefit for antioxidant therapies for the prevention of cisplatin-induced hearing loss. More high-quality studies are needed to fill in the identified gaps in knowledge.
    Keywords hearing loss ; ototoxicity ; supportive care
    Language English
    Publishing date 2022-06-27
    Publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
    Publishing place Stuttgart ; New York
    Document type Article
    ISSN 2455-4618 ; 2454-6798
    ISSN (online) 2455-4618
    ISSN 2454-6798
    DOI 10.1055/s-0042-1748637
    Database Thieme publisher's database

    More links

    Kategorien

  2. Article ; Online: The Impact of Malnutrition on the Quality of Life of Colorectal Cancer Patients in a Tertiary Hospital.

    Velasco, Rogelio N / Catedral, Lance Isidore G / Chua, Alfredo V / Hernandez, Aylmer Rex B / King, Rich Ericson C / Leones, Louis Mervyn B / Mondragon, Karen Anjela M / Ting, Frederic Ivan L / Callueng, Jose Miguel C / Tampo, Mayou Martin T / Sacdalan, Dennis Lee

    Nutrition and cancer

    2022  Volume 74, Issue 8, Page(s) 2937–2945

    Abstract: Malnutrition among colorectal cancer patients can impair quality of life and decrease survival. This study evaluated the nutritional status of colorectal cancer patients and its association with quality of life among Filipino colorectal cancer patients ... ...

    Abstract Malnutrition among colorectal cancer patients can impair quality of life and decrease survival. This study evaluated the nutritional status of colorectal cancer patients and its association with quality of life among Filipino colorectal cancer patients seen in a tertiary hospital. A cross-sectional study was conducted among colorectal cancer patients seen at the Philippine General Hospital between December 1, 2019 and February 28, 2020. Nutritional status was evaluated using the Subjective Global Assessment, while quality of life was assessed using the EORTC QLQ-C30. Descriptive statistics, ANOVA and logistic regression were employed for analysis. Among 292 patients, malnutrition was noted in 76.4%. Stage III cancer had a higher odds for malnutrition (OR (odds ratio) = 6.22, 95% confidence interval (CI): 1.59, 24.42). Patients who received or were currently receiving chemotherapy were less likely to develop malnutrition (OR = 0.35, 95% CI: 0.18-0.69). Global health status and all functional subscale scores for the severely malnourished group were lower while the scores for symptom scales increased with the degree of malnutrition. There was a high prevalence of malnutrition among colorectal cancer patients and this was associated with poor quality of life. Future directions emphasizing early nutritional screening and assessment are recommended.
    MeSH term(s) Cross-Sectional Studies ; Humans ; Malnutrition/diagnosis ; Malnutrition/epidemiology ; Malnutrition/etiology ; Neoplasms/epidemiology ; Nutrition Assessment ; Nutritional Status ; Quality of Life ; Surveys and Questionnaires ; Tertiary Care Centers
    Language English
    Publishing date 2022-02-26
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 424433-3
    ISSN 1532-7914 ; 0163-5581
    ISSN (online) 1532-7914
    ISSN 0163-5581
    DOI 10.1080/01635581.2022.2044061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Rare case of intramedullary spinal cord metastasis from nasopharyngeal carcinoma.

    Alonto, Anisah Hayaminnah D / Mondia, Mark Willy L / Planilla, Cyril Jonas M / Mendoza, Marvin Jonne L / Urquiza, Sheen C / King, Rich Ericson C / Bagnas, Marjorie Anne C

    Current problems in cancer

    2021  Volume 45, Issue 6, Page(s) 100713

    Abstract: Introduction: Central nervous system (CNS) metastasis from nasopharyngeal carcinoma (NPC) is rare and presents with high morbidity and mortality. As a rare entity, a few patients with CNS metastasis from NPC have been reported, and no studies were ... ...

    Abstract Introduction: Central nervous system (CNS) metastasis from nasopharyngeal carcinoma (NPC) is rare and presents with high morbidity and mortality. As a rare entity, a few patients with CNS metastasis from NPC have been reported, and no studies were available on treatment and prognosis. Based on our clinical experience, early diagnosis with incorporation of a clear palliative plan is imperative in providing holistic care for patients with locally-invasive and metastatic nasopharyngeal carcinoma.
    Case report: Our study reports a case of a 48-year-old Filipino male with known NPC Stage IVB who developed acute symptoms of constipation, urinary retention, and bilateral lower limb weakness and numbness. Magnetic resonance imaging showed intramedullary lesions in multiple segments of the spinal cord. Steroid and radiotherapy of the spine were initiated with noted transient improvement of the motor strength. Subsequently, he developed cancer-related stroke. The patient progressively deteriorated despite best medical care.
    MeSH term(s) Carcinoma, Squamous Cell/pathology ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma/pathology ; Nasopharyngeal Neoplasms/pathology ; Philippines ; Spinal Cord Neoplasms/secondary ; Spinal Cord Neoplasms/therapy ; Treatment Outcome
    Language English
    Publishing date 2021-02-09
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 441816-5
    ISSN 1535-6345 ; 0147-0272
    ISSN (online) 1535-6345
    ISSN 0147-0272
    DOI 10.1016/j.currproblcancer.2021.100713
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: The Impact of Malnutrition on the Quality of Life of Colorectal Cancer Patients in a Tertiary Hospital

    Velasco, Rogelio N. / Catedral, Lance Isidore G. / Chua, Alfredo V. / Hernandez, Aylmer Rex B. / King, Rich Ericson C. / Leones, Louis Mervyn B. / Mondragon, Karen Anjela M. / Ting, Frederic Ivan L. / Callueng, Jose Miguel C. / Tampo, Mayou Martin T. / Sacdalan, Dennis Lee

    Nutrition and cancer. 2022 July 25, v. 74, no. 8

    2022  

    Abstract: Malnutrition among colorectal cancer patients can impair quality of life and decrease survival. This study evaluated the nutritional status of colorectal cancer patients and its association with quality of life among Filipino colorectal cancer patients ... ...

    Abstract Malnutrition among colorectal cancer patients can impair quality of life and decrease survival. This study evaluated the nutritional status of colorectal cancer patients and its association with quality of life among Filipino colorectal cancer patients seen in a tertiary hospital. A cross-sectional study was conducted among colorectal cancer patients seen at the Philippine General Hospital between December 1, 2019 and February 28, 2020. Nutritional status was evaluated using the Subjective Global Assessment, while quality of life was assessed using the EORTC QLQ-C30. Descriptive statistics, ANOVA and logistic regression were employed for analysis. Among 292 patients, malnutrition was noted in 76.4%. Stage III cancer had a higher odds for malnutrition (OR (odds ratio) = 6.22, 95% confidence interval (CI): 1.59, 24.42). Patients who received or were currently receiving chemotherapy were less likely to develop malnutrition (OR = 0.35, 95% CI: 0.18–0.69). Global health status and all functional subscale scores for the severely malnourished group were lower while the scores for symptom scales increased with the degree of malnutrition. There was a high prevalence of malnutrition among colorectal cancer patients and this was associated with poor quality of life. Future directions emphasizing early nutritional screening and assessment are recommended.
    Keywords colorectal neoplasms ; confidence interval ; cross-sectional studies ; descriptive statistics ; drug therapy ; health status ; hospitals ; malnutrition ; nutritional status ; odds ratio ; quality of life ; regression analysis
    Language English
    Dates of publication 2022-0725
    Size p. 2937-2945.
    Publishing place Taylor & Francis
    Document type Article
    ZDB-ID 424433-3
    ISSN 1532-7914 ; 0163-5581
    ISSN (online) 1532-7914
    ISSN 0163-5581
    DOI 10.1080/01635581.2022.2044061
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article: Follicular Dendritic Cell Sarcoma of the Tonsil: A Multimodality Approach.

    King, Rich Ericson C / Villaruel, Andrea R / Magno, Jose Pedrito M / de Guzman, Sean Patrick C / Catedral, Lance Isidore G / Mondragon, Karen Anjela M / Ting, Frederic Ivan L / Velasco, Rogelio N / Fernando, Gracieux Y

    Journal of medical cases

    2020  Volume 11, Issue 10, Page(s) 309–316

    Abstract: Follicular dendritic cell sarcoma (FDCS) accounts for < 0.4% of soft tissue sarcomas. Only 35 cases of tonsillar FDCS have been reported, and majority had localized presentation. We present a case of FDCS of the tonsil, wherein a well-coordinated ... ...

    Abstract Follicular dendritic cell sarcoma (FDCS) accounts for < 0.4% of soft tissue sarcomas. Only 35 cases of tonsillar FDCS have been reported, and majority had localized presentation. We present a case of FDCS of the tonsil, wherein a well-coordinated trimodality approach provided good disease control in advanced disease. A 53-year-old man presented with a painless and enlarging neck mass of 11-month duration, with no other symptoms. Close examination revealed a 10 × 5 cm mass at the left carotid triangle, and a 3.2 × 2.2 cm mass at the left tonsillar fossa. Imaging revealed the tumor to be unresectable due to its attachment to the great vessels. There were no distant metastases. Biopsy and immunohistochemistry were initially deemed consistent with an undifferentiated sarcoma. Palliative chemotherapy was given using single agent doxorubicin and subsequent dacarbazine, resulting in partial response and stable disease, respectively. Pathological re-evaluation was pursued because of the uncharacteristic slow progression of the tumor, revealing diffuse positivity for CD21 and negative for CD1A and CD34, consistent with FDCS. The patient underwent three cycles of gemcitabine plus docetaxel resulting in 50% regression. This allowed dissection of level IB-V lymph nodes and subsequent radiotherapy for the neck and tonsillar mass, with weekly gemcitabine as a radiosensitizer. Evaluation 8 months post-treatment showed no signs of disease progression. Treatment-related complications included radiation dermatitis and swallowing dysfunction, which both resolved on follow-up. This case highlights the multidisciplinary management of a rare type of sarcoma in an uncommon anatomic location. Precise pathologic diagnosis is important in soft tissue sarcoma because of its therapeutic implications. For FDCS, effective response may still be achieved in the third-line setting.
    Language English
    Publishing date 2020-08-28
    Publishing country Canada
    Document type Case Reports
    ZDB-ID 2586383-6
    ISSN 1923-4163 ; 1923-4155
    ISSN (online) 1923-4163
    ISSN 1923-4155
    DOI 10.14740/jmc3551
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top